Medical Laboratory Personnel Shortage Relief Act Aims to Dent the Staffing Crisis
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Recent government efforts to address increased cyberattacks in the healthcare space, and how your lab could benefit
How clinical laboratories and pathology groups can ensure that their digital pathology and AI workflows are HIPAA-compliant
Direct-to-consumer (DTC) genetic testing has risen in popularity in recent years—but is it all it’s cracked up to be?
For clinical labs, the proposed law could bring more consistency to test ordering
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Curious about how laboratory-developed tests are regulated in other countries? We compare in-house test guidance across six regions
Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.